About Us
About
As a proud member of the Mahfel Holding Group, we’ve been actively contributing to Turkey’s healthcare sector since 2022. Through the production and distribution of premium medical equipment and pharmaceutical raw materials, we strive to add real value to the industry. We're growing and evolving every day to bring you the highest quality products. We're driven by the trust you place in us and are excited to deliver dependable, effective solutions for your health.
Our Partners
Our Services
Global trade & supply chain management
We are a trusted business partner specializing in global trade, offering supply chain management solutions tailored specifically for the healthcare se...
We are a trusted business partner specializing in global trade, offering supply chain management sol...
Import & export services
At Mahfel Medical, we provide specialized import and export services in the medical sector. We manage your international trade processes within the fr...
At Mahfel Medical, we provide specialized import and export services in the medical sector. We manag...
International consulting
We provide strategic consulting support to companies operating in the medical and pharmaceutical sectors as they expand into international markets. To...
We provide strategic consulting support to companies operating in the medical and pharmaceutical sec...
Pharmaceutical sourcing & supply
We provide high value-added solutions to the healthcare industry through reliable and traceable pharmaceutical supply chain systems that comply with i...
We provide high value-added solutions to the healthcare industry through reliable and traceable phar...
Our Products
Blog
New Genetic Signature Discovered to Personalize Immunotherapy Treatments
Scientists have identified a new genetic signature in T cells that could help tailor immunotherapy treatments to individual patients. This discovery may lead to more effective and personalized cancer therapies in the near future.
Read More
Your Baby’s First Steps May Be Linked to Genetics
A study found that the timing of a baby’s first steps is linked to genetic factors, which may also relate to brain development.
Read More
AI Predicts Biological Age and Cancer Risk from Facial Images
Researchers at Massachusetts General Brigham have developed an AI tool that predicts biological age and cancer risk based on facial images.
Read More
Vitamin supplements slow down the progression of glaucoma
A vitamin supplement that improves eye metabolism has been found to slow optic nerve damage in glaucoma patients.
Read More
Annual blood test could detect cancer earlier and save lives
A new modeling study suggests that an annual blood test could detect various types of cancer at an early stage, potentially saving lives.
Read More
AR & VR in Medical Training and Theraphy
Virtual and augmented reality technologies are being used in everything from surgical education to pain management. VR-based therapies can reduce perceived pain by 24% in chronic pain patients.
Read MoreEvents
Latest News
Australia Approves Donanemab: A Historic Step in Alzheimer’s Treatment
Australia has approved an alternative Alzheimer's treatment for the first time in 25 years. Donanemab, developed by Eli Lilly, targets amyloid plaques in the brain to slow memory loss and cognitive decline in early-stage patients. The drug, administered monthly, can be effective for up to 18 months and costs approximately 4,700 Australian Dollars per prescription.
Obese Individuals Are More Susceptible to Long COVID Symptoms
Researchers at Edith Cowan University found that obese individuals are more susceptible to experiencing long COVID symptoms.
Effective Protection Against RSV Virus: 78% Fewer Hospitalizations with Nirsevimab
Spanish study shows nirsevimab significantly reduces RSV-related hospitalizations in infants by 78%.